Similar articles for PMID: 30877177

Year	Number of Results
1998	1
2000	1
2002	1
2005	2
2007	2
2008	1
2009	2
2010	1
2011	7
2012	12
2013	11
2014	10
2015	18
2016	15
2017	20
2018	27
2019	36
2020	42
2021	39
2022	28
2023	11
2024	0

1

Accuracy of ¹⁸F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R. Valkema MJ, et al. J Nucl Med. 2019 Nov;60(11):1553-1559. doi: 10.2967/jnumed.118.224196. Epub 2019 Mar 15. J Nucl Med. 2019. PMID: 30877177 Free article. Clinical Trial.

2

Surveillance of Clinically Complete Responders Using Serial ¹⁸F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy.

Valkema MJ, van der Wilk BJ, Eyck BM, Wijnhoven BPL, Spaander MCW, Doukas M, Lagarde SM, Schreurs WMJ, Roef MJ, van Lanschot JJB, Valkema R. Valkema MJ, et al. J Nucl Med. 2021 Apr;62(4):486-492. doi: 10.2967/jnumed.120.247981. Epub 2020 Sep 4. J Nucl Med. 2021. PMID: 32887759 Free PMC article.

3

Diffusion-weighted MRI and ¹⁸F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM. Xu X, et al. Radiat Oncol. 2021 Jul 19;16(1):132. doi: 10.1186/s13014-021-01852-z. Radiat Oncol. 2021. PMID: 34281566 Free PMC article.

4

Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using ¹⁸F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.

Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, Lam MGEH, van Lier ALHMW, Mook S, Ruurda JP, van Vulpen M, Voncken FEM, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ. Borggreve AS, et al. Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):998-1009. doi: 10.1016/j.ijrobp.2019.12.038. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987972 Free PMC article. Clinical Trial.

5

Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment ¹⁸F-FDG PET/CT Imaging.

Beukinga RJ, Hulshoff JB, van Dijk LV, Muijs CT, Burgerhof JGM, Kats-Ugurlu G, Slart RHJA, Slump CH, Mul VEM, Plukker JTM. Beukinga RJ, et al. J Nucl Med. 2017 May;58(5):723-729. doi: 10.2967/jnumed.116.180299. Epub 2016 Oct 13. J Nucl Med. 2017. PMID: 27738011 Free article.

6

Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.

Stiekema J, Vermeulen D, Vegt E, Voncken FE, Aleman BM, Sanders J, Boot H, van Sandick JW. Stiekema J, et al. Clin Nucl Med. 2014 Oct;39(10):862-7. doi: 10.1097/RLU.0000000000000517. Clin Nucl Med. 2014. PMID: 25140549

7

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging ¹⁸F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer.

Beukinga RJ, Hulshoff JB, Mul VEM, Noordzij W, Kats-Ugurlu G, Slart RHJA, Plukker JTM. Beukinga RJ, et al. Radiology. 2018 Jun;287(3):983-992. doi: 10.1148/radiol.2018172229. Epub 2018 Mar 14. Radiology. 2018. PMID: 29533721

8

FDG PET using SUV_max for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy.

Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH. Huang YC, et al. BMC Med Imaging. 2017 Jan 5;17(1):1. doi: 10.1186/s12880-016-0171-7. BMC Med Imaging. 2017. PMID: 28056868 Free PMC article.

9

Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.

Eyck BM, Onstenk BD, Noordman BJ, Nieboer D, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB. Eyck BM, et al. Ann Surg. 2020 Feb;271(2):245-256. doi: 10.1097/SLA.0000000000003397. Ann Surg. 2020. PMID: 31188203

10

18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.

Chirindel A, Chaudhry M, Blakeley JO, Wahl R. Chirindel A, et al. J Nucl Med. 2015 Mar;56(3):379-85. doi: 10.2967/jnumed.114.142372. Epub 2015 Feb 5. J Nucl Med. 2015. PMID: 25655626 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

252 results

Results by year